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A B S T R A C T   
Frequent consumption of pharmaceuticals and personal care products (PPCPs) have emerged as a current 
problem that highlights the pressing need for new multi-residue analytical methods that allow their simultaneous 
determination to assess their overall effect on human health. In this regard and for the first time, a versatile 
microfluidic based- liquid phase microextraction (LPME) method was developed for simultaneous monitoring of 
ten compounds from six different classes: amoxicillin, sulfadiazine, sulfamerazine, tiamphenicol, ethyl 4-hydrox-
ybenzoate, flumequine, propyl 4-hydroxybenzoate, 5-hydroxydiclofenac, 3-hydroxydiclofenac and diclofenac. 
The microfluidic device was combined with a HPLC-UV system for the separation and determination of the model 
analytes in the sample. Optimal conditions were reached using 2-nitrophenyl octyl ether as supported liquid 
membrane, pH 3.5 as donor phase, pH 11.5 as acceptor phase, 0.5 µL min− 1 as donor flow rate and 1 µL min− 1 as 
acceptor flow rate. Under optimal method conditions, the extraction efficiency was between 85 and 100% for 
most compounds after 10 min extraction, and it was successfully applied in non-diluted human urine, with re-
coveries between 70 and 100% for all analytes except for sulfamerazine (52% recovery). In addition, the 
extraction of metabolites (3-hydroxydiclofenac and 5-hydroxydiclofenac) was also demonstrated in microfluidic 
systems with recoveries between 71 and 100% in human urine. The proposed method allowed consecutive 
extraction and only requires 5 µL of organic solvent and less than 15 µL of sample volume.   
1. Introduction 
The analysis of drugs and parabens in biological samples has gained 
special importance over the years due to the adverse effects that their 
accumulation can cause in human health. The presence of parabens in 
urine may be associated, on the one hand, with accidental exposure to 
paraben-containing products and, to a lesser extent, with environmental 
exposure, as their systemic absorption has been previously described in 
both cases [1,2]. On the other hand, these well-known ubiquitous pre-
servatives, have been linked to adverse health outcomes in humans, 
specially they may act as weak endocrine disrupters, however, contro-
versy still surrounds this fact, what evidence the need for further studies 
that include them among other compounds [3]. Due to their frequent co- 
administration with principal active ingredients, as excipients, in many 
pharmaceutical formulations, they are expected to be present in samples 
from individuals undergoing drug treatment. This fact highlights the 
need to develop analytical methods that allow simultaneous determi-
nation of different nature compounds to carry out more complex studies, 
even including the evaluation of possible synergistic or antagonistic 
effects between them. 
Liquid phase microextraction (LPME) in different configurations has 
been proved to be a powerful tool [4] for extracting compound with the 
same acidic or basic nature [5,6] or from the same family of compounds, 
such as for example, non-steroidal anti-inflammatories [7,8], parabens 
[9–10], sulfonamides [11–13], fluoroquinolones [14,15], amphet-
amines [16], etc. On another hand, other components of the matrix can 
make analysis difficult. Therefore, finding an appropriate strategy which 
can simultaneously extract different class of analytes with excellent 
clean-up is of great importance. Various procedures have been presented 
to overcome this shortcoming for instance using different sorbents with 
various polarities, sorbents with different functional groups, combina-
tion of polymers and reduction the polar compounds. Nevertheless, they 
are faced with the challenge of improving greener and faster procedures 
disable to ensure efficient, accurate and facilitated extraction methods 
for simultaneous monitoring different types of analytes. To fulfil green 
analytical chemistry requirements, LPME has been miniaturized and this 
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has led to facilitate not only the automation of this technique but also to 
require a lower volume of extractant and sample volume, the latter 
being of crucial importance especially when very small volume of bio-
logical sample is available. The most used microfluidic system when 
implementing LPME consists of two channels (one for the donor phase 
and one for the acceptor phase) that are separated through a flat 
membrane, which supports an organic solvent. The dimensions of the 
channels are on the order of millimeters and the volume they contain on 
the order of microliters. In this way, the analytes present in the sample 
(in their neutral form) are extracted from the donor to the acceptor 
phase (ionized form) through the membrane by passive diffusion. 
Miniaturization in the form of channels accelerates the mass transfer of 
analytes from one phase to another. To date, microfluidic based liquid 
phase microextraction procedures has only been mainly optimized for 
the extraction of compounds belonging to the same class [17–20], or 
same acidic or basic nature [21,22]. It has been possible to extract acidic 
and basic compounds simultaneously by using single or double elec-
tromembrane (EME) technique using a sample volume consumption of 
the order of milliliters and stagnant conditions (traditional set-up), 
[23–26] which has recently been improved in microfluidic systems in 
order to minimize the organic solvent and sample volume consumption 
[27–29]. However, electromembrane technique requires a power supply 
and two electrodes so that the analytes can electromigrated through the 
membrane due to a potential difference applied between the two elec-
trodes. In addition, the number of EME-compatible conductive solvents 
is reduced, the optimal voltage can be critical depending on the nature 
and functional group, and the system as a whole consumes more energy. 
The simultaneous extraction of compounds from different nature or 
different families by microfluidic systems based LPME represents still a 
great challenge. The efficiency and selectivity of the extraction in LPME 
depends mainly and critically on the type of organic solvent used as the 
supported liquid membrane (SLM) as well as on the other parameters 
such as the composition of the donor and acceptor phase, since the 
compounds (independently of their nature or functional group) must be 
predominantly in their neutral or ionized form in the donor and acceptor 
phase, respectively. 
In this work, an efficient microfluidic-based liquid phase micro-
extraction method is developed for simultaneously monitoring of ten 
compounds belonging to six different classes of analytes in human urine. 
For the first time, not only the simultaneous extraction of compounds of 
a very different nature has been demonstrated, but the extraction of 
metabolites in microfluidic systems. 
2. Experimental 
2.1. Chemicals and materials 
Sulfadiazine (SDI), sulfamerazine (SMI), ethyl 4-hydroxybenzoate 
(EtP), propyl 4-hydroxybenzoate (PrP), diclofenac (DIC), 5-hydroxydi-
clofenac (5-OH), 3- hydroxydiclofenac (3-OH), amoxicillin (AOX), flu-
mequine (FLU), tiamphenicol (TMF) were provided from Fluka-Sigma- 
Aldrich (Madrid, Spain). Formic acid, sodium hydroxide, chloric acid, 
2-nitrophenyl octyl ether (NPOE), dihexyl ether, and 1-octanol were 
purchased from Fluka-Sigma-Aldrich (Madrid, Spain). Analytical- 
reagent grade including methanol, acetonitrile, decanol, and tributyl 
phosphate (TBP) were supplied from Merck (Darmstadt, Germany). In-
dividual stock solutions of each compound were prepared in methanol 
(100 mg L− 1) and stored at 4 ◦C in a refrigerator. The stock solution of 5- 
hydroxydiclofenac, 3- hydroxydiclofenac were prepared in ultrapure 
water and stored at − 70 ◦C in light resistant before use. Further dilutions 
and mixtures were daily prepared by dilution from the stock standard 
solutions in ultrapure water 18,2 MΩ.cm (Millipore, Billerica, MA, USA). 
Two micro-syringe pumps (Cetoni GmbH, Korbussen, Germany) were 
used to introduce the donor and acceptor phase solutions into the 
microchip device. 
2.2. Chromatographic conditions 
The HPLC system consisted of a VWR-Hitachi (Barcelona, Spain) 
liquid chromatograph with a quaternary L-2130 pump. The injector was 
an autosampler L-2200. Separation was performed using a LiChroCART 
75–4 Purosphere STAR RP-18e 3 µm (75 mm × 4.0 mm i.d.) (VWR, 
Germany) proceeded by a guard column Kromasil1 100 Å, C18, 5 µm 
(20 mm × 4.6 mm i.d.) (Scharlab S.L., Barcelona, Spain). The mobile 
phase consisted of 0.1% formic acid (pH 2.6) (component A) and 
methanol (component B) at a flow rate of 0.5 mL min− 1. The gradient 
elution was programmed as follows: a gradient mode from 80% A to 
60% A for 3 min and from 60% to 40% A for 2 min and then keep those 
conditions in isocratic mode for another 2 min. Then, from 40% to 20% 
A for 4 min and keep it in isocratic mode for 4 min. Finally, from 20% A 
to 5% A for 5 min. To achieve the reequilibration of the column to the 
initial conditions, 5 min were waited between injections. The wave-
lengths selected for diode array detector (DAD) were 230 (for AOX), 240 
(for EtP), 249 (for FLU), 255 (for PrP), 267 (for SDI, SMI and TMF) and 
275 nm (for 5-OH, 3-OH and DIC). The chromatogram was completed in 
less than 20 min and the retention time was 3.57, 4.03, 5.81, 8.20, 
11.84, 12.72, 13.84, 14.61, 15.17 and 17.76, for AOX, SDI, SMI, TMF, 
EtP, FLU, PrP, 5-OH, 3-OH and DIC, respectively. 
2.3. Chip design and liquid phase microextraction methodology 
A laser ablation cutter was used for microfluidic device micro-
fabrication (Epilog Mini 24–30 W). The optimal poly(methyl methac-
rylate) (PMMA) device was comprised of two symmetric patterned 
layers with one channel each (0.070 mm depth × 27 mm width × 23 mm 
length) along with six holes of 3 mm for assembling and four holes of 
1.35 mm diameter as inlets and outlets (Fig. 1). A flat polypropylene 
membrane piece separated the acceptor and donor phase. The flat 
polypropylene membrane supported 3 μL NPOE covering the whole 
channel surface. The microchip device was opened and the membrane 
was replaced when needed. The acceptor and donor inlets (Inlets Teflon 
tubes) were connected to two separate micro-syringe pumps to intro-
duce the donor (pH 3.5) and acceptor solutions (pH 11.5) into the 
microfluidic device. After 10 min for SLM stabilization to ensure both 
channels are bubble free, the extraction was operated for 12 min at 0.5 
and 1 µL min− 1 as donor and acceptor flow rates, respectively. After 
extraction, the acceptor phase was collected in a microinsert tube, and 
10 µL of the collected solvent was injected into the HPLC-UV port for 
analysis. 
2.4. Real samples 
Urine samples were collected from a 30 year old volunteer. Non- 
diluted urine samples were spiked at three different concentration 
levels (low, medium and high) within the linear range of each analyte, 
and then it was adjusted to pH 3.5 with HCl solution. In addition, five 
urine samples were collected at intervals of 30 min between them after a 
volunteer took a single oral dose of 50 mg of diclofenac. All samples 
were filtrated through Pall NylafloTM nylon membrane filter 0.45 µm 
(Pall Corporation, Ann Arbor, Michigan, USA) and then submitted to the 
microfluidic device for extraction. 
3. Results and discussion 
3.1. Optimization and evaluation of experimental parameters 
Passive diffusion of the analytes between donor and acceptor phase 
mainly depends on the composition of the supported liquid membrane 
and physico-chemical properties of the analytes (log P and pKa values). 
On the other hand, mass transfer rate between donor and acceptor de-
pends on the surface contact. In this regard, the influence of chip ge-
ometry was investigated using an initial device of 23 mm length, 70 μm 
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deep and 3 mm wide based on our previous studies [20,30]. First, the 
characteristics of the supported liquid membrane was comprehensively 
studied. Afterward, the influence of donor and acceptor phase compo-
sition and the flow rates were optimized. 
3.1.1. Supported liquid membrane optimization 
Initial tests were carried out to select an appropriate supported liquid 
membrane for all compounds from different nature. Different solvents 
related to the extraction of acidic or basic compounds were tested based 
on the reported literature [30–32]: 2-nitrophenyl octyl ether (NPOE), 
dihexyl ether (DHE), tributyl phosphate (TBP), decanol, octanol and 
some mixtures among those that offer better results. The preliminary 
conditions of donor and acceptor phase composition were studied based 
on their pKa values. The compounds studied have different pKa values 
[33–36]: pKa of 2.8 and 7.2 for AOX; pKa of 1.6 and 6.5 for SDI; pKa of 
1.58 and 6.9 for SMI; pKa of 8.9 for EtP and PrP; pKa of 4.5 for DIC; pKa of 
7.4 for TFM and pKa of 6.7 for FLU.A pH below the pKa value for analytes 
with acid groups and between the two pKa values for compounds con-
taining amino groups was selected as preliminary donor phase compo-
sition to ensure that the predominant species of each analyte is neutral in 
that phase. The selected acceptor phase pH value was above the pKa 
value of each analyte (regardless of whether they have one or two pKa 
values) to ensure that the species formed is ionized. Based on that, donor 
phase composition, acceptor phase composition and flow rates were 
preliminary fixed at pH 3.0 (HCl), pH 12 (NaOH) and 1 μL min− 1, 
respectively. A new membrane was placed for each organic solvent test 
and three consecutive extractions were carried out for each solvent. As 
seen in Table 1, NPOE and decanol showed efficiencies between 22 and 
97% and 6–60%, respectively, for all compounds. DHE and octanol 
showed efficiencies between 8 and 54% and 4–54%, respectively, for all 
compounds except for TMF. Based on the results, two mixtures NPOE: 
TBP 1:1 and DHE:TBP 1:1 were also tested but as seen in Table 1, only 
good efficiencies between 40 and 70% were obtained for AOX, SDI, SMI 
and TMF. As is known, the affinity of each compound for a certain SLM 
will depend on the physical–chemical characteristics and the structure 
of each compound. For this reason, some compounds such as TFM are 
more related to TBP: NPOE 1: 1, while the rest are related to NPOE. For 
this reason, a compromise is reached for the SLM that is more efficient 
for most of the compounds. Consequently, NPOE was selected as SLM for 
further experiments since it showed the highest efficiencies for all 
compounds. 
3.1.2. Donor and acceptor solutions composition 
The pH composition of donor and acceptor phase plays a critical role 
on the diffusion coefficient in liquid based microextraction methods. 
Due to the variety of functional groups and pKa values of the analytes, 
donor phase composition (containing 1 mg L-1 of each compound) was 
tested between 1 and 7 pH. SLM, acceptor phase composition and flow 
rate were fixed with NPOE, at pH 12 (NaOH) and 1 µL min− 1, respec-
tively. As shown in Fig. 2, the optimal extraction efficiencies were ob-
tained at pH 3.5 for all compounds, except for SDI and SMI, which 
showed a slight increase in extraction at pH 3 due to their pKa values. 
Fig. 1. Scheme of the microfluidic device based liquid phase microextraction.  
Table 1 
Extraction efficiencies (RSD %) of the analytes using different organic solvents as SLM.  
SLM/compounds AOX SDI SMI TMF ETY FLU PRO 3-OH 5-OH DIC 
Octanol 54 (3) 26 (2) 35 (5) n.d (3) 17 (4) 34 (2) 4 (2) 10 (3) 13 (2) 12 (4) 
NPOE 81 (4) 54 (2) 69 (3) 22 (2) 96 (3) 97 (6) 95 (2) 91 (2) 67 (3) 92 (4) 
TBP 72 (2) 44 (3) 41 (2) 13 (2) n.d n.d n.d 10 (3) n.d n.d 
Decanol 60 (3) 16 (2) 26 (4) 6 (3) 41 (3) 44 (2) 37 (2) 31 (5) 27 (2) 44 (5) 
DHE 35 (6) 8 (2) 10 (4) – 37 (2) 47 (6) 54 (3) 48 (4) 30 (3) 41(2) 
TBP:NPOE 1:1 70 (3) 43(6) 51(3) 75 (6) n.d n.d n.d 10 (4) n.d n.d 
TBP:DHE 1:1 60 (2) 38 (4) 50 (2) 50 (3) n.d 9 (3) n.d 8 (2) n.d n.d 
n.d: non detected. 
S. Dowlatshah et al.                                                                                                                                                                                                                            
Microchemical Journal 169 (2021) 106577
4
Then, a pH 3.5 was selected showing the highest extraction efficiency for 
most of the compounds. The acceptor phase pH was optimized within 
the range 9.0–12.5 by keeping the optimal donor pH (3.5) fixed. Based 
on the data in Fig. 3, pH 11.5 can be considered as the most appropriate 
point for the compounds since the highest extraction efficiencies were 
obtained for most of the compounds. Only SMI, 5-OH and 3-OH showed 
better efficiencies at pH 12, 11 and 10, respectively. Under these con-
ditions (pH 3.5 and pH 11.5 as donor and acceptor phase composition, 
respectively), the compounds are predominantly in their neutral form in 
the donor phase and charged in the acceptor phase. 
In addition to initially selecting a suitable SLM for most compounds, 
the selection of the composition of the acceptor and donor phase is 
decisive, especially when it comes to different classes of compounds 
with very different acid constants. The optimal conditions selected 
correspond to the best efficiencies for most compounds. However, three 
compounds are more efficiently extracted using selectively other con-
ditions, such as 1: 1 NPOE: TBP solvent for TFM and pH 4 conditions for 
SDI and SMI. 
3.1.3. Donor flow rate and geometry optimization 
Sample flow rate was tested between 0.5 and 10 µL min− 1 while the 
acceptor flow rate was fixed at 1 µL min− 1. Previous studies have shown 
that the extraction efficiency would significantly decrease with greater 
acceptor flow since the time that this phase is in contact with the donor 
phase (containing the analytes) will decrease [17,21]. For this reason, 
the acceptor flow has been set to 1 µL min− 1 avoiding loss of extraction 
efficiency. As seen in Fig. 4, the extraction efficiency decreased with 
increasing flow rate. This phenomenon might be due to decreasing the 
residence time of the sample during flow rate enhancement. Thus, 0.5 
µL min− 1 was selected as donor flow rate. 
The geometry in terms of length, depth and width of microchannel 
was studied. In this way, three devices with different length (mm), width 
(mm) and depth (mm) sizes were utilized with the following charac-
teristics: (a) 23x3x0.07, (b) 13x3x0.12, (c) 13x3x0.07 and (d) 
23x3x0.14. Extraction efficiencies between 53 and 100%, 7–108%, 
51–110% and 6–103% were obtained for the device (a), (b), (c) and (d), 
respectively. The geometry (a) showed the highest efficiencies 
compared to (b) and (d) and slightly higher efficiencies compared to (c) 
Geometry 23 × 3 × 0.07 was selected as the optimal one although no 
significant differences were observed between device (a) and (c). 
The method provides good extraction efficiencies after only 10 min 
extraction, requires 10 µL of sample, 3 µL of organic solvent and allow 
consecutive extractions. 
3.2. Analytical performance 
Under optimal conditions, different experiments were performed to 
evaluate the analytical performances of the proposed microfluidic 
method. Linearity, repeatability, method detection limits (MLODs), and 
method quantitation limits (MLOQs) were calculated and summarized in 
Table 2. A calibration curve was constructed using a least-square linear 
regression analysis at eight different concentrations within the linear 
range. The linearity range was 0.3–10 μg mL− 1 for SMI, EtP and PrP, 
0.83–10 μg mL− 1 for TMF, FLU and 3-OH, 0.1–10 μg mL− 1 for SDI, 
2.6–10 μg mL− 1 for AOX and 5-OH; and 0.14–10 for DIC. A linear 
relationship with r2 values over 0.9996 was obtained in all cases. LODs 
(S/N = 3) and LOQs (S/N = 10) were between 0.04 and 10 μg mL− 1 and 
0.1–10 μg mL− 1 for all compounds, respectively. Extraction efficiencies 
were also shown in Table 2 based on three replicate experiments with 
relative standard deviation below 6% in all cases. Efficiencies were be-
tween 54 and 100% for all analytes except for TMF which was lower 
(35%). Repeatability (n = 4) and intraday repeatability (n = 4, 15 days) 
Fig. 2. Optimization of donor phase composition. SLM: NPOE, acceptor phase pH: 12, flow rate: 1 μL min− 1 (acceptor and donor phase).  
Fig. 3. Optimization of acceptor phase composition. SLM: NPOE, donor phase pH: 3.5, flow rate: 1 μL min− 1 (acceptor and donor phase).  
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were studied at three different levels (low, medium, high) of the cali-
bration curve of each analyte, obtaining a relative standard deviation 
below 6% and below 5% for repeatability and intraday repeatability, 
respectively. Reproducibility of the device was tested replacing three 
times the membrane, observing a relative standard deviation below 5% 
for all analytes. 
3.3. Real samples 
Human urine samples were collected from a 30 year-old healthy 
adult female volunteer (staff working in the laboratory) to show appli-
cability. Non-diluted urine sample was directly spiked at two different 
concentration levels and each concentration was tested in triplicate. 
After the pH adjustment of the sample, it was submitted to the micro-
fluidic device and the acceptor phase collected was analyzed by HPLC. 
As seen in Table 3, the spiking recoveries (n = 3) were between 70 and 
100% for all analytes (AOX, SDI, TMF, EtP, FLU, PrP, 3-OH, 5-OH and 
DIC) except for SMI (52% recovery) with a relative standard deviation 
below 6% for all analytes. Recovery was not influenced by the level of 
spiking in the urine samples. The same volunteer took a single oral dose 
of 50 mg of diclofenac and urine samples were collected at intervals of 
30 min observing 1.6 mg L-1, 2 mg L-1, 2.5 mg L-1, 3.1 mg L-1 of the 
metabolite 5-OH after 30, 60, 90 and 120 min, respectively. Membrane 
was stable for at least 10 consecutive extractions in urine samples 
without carry over effect. Fig. 5 shows the corresponding DAD chro-
matogram from (A) spiked human urine and (B) blank urine sample. 
4. Conclusions 
In this work, an effective downscaled microfluidic device was pro-
posed for simultaneous monitoring of ten compounds from six different 
families including two metabolites in human urine. NPOE proved to be a 
compatible solvent for the extraction of compounds of a very different 
nature. In most compounds, the efficiency is higher than 85%, and in 
those in which the efficiency is slightly lower (SDI, SMI and TMF), it is 
due to the commitment in which the extraction conditions have been set 
and can be modified to benefit the extraction of other compounds. As 
explained above, the physical–chemical and structural characteristics of 
the compounds analyzed are very different and the optimal operational 
parameters vary for the case of these three compounds. This method also 
benefits from the low sample volumes required (15 µL), low organic 
solvent volume (3 µL) and a short extraction time (15 min). The method 
has been successfully applied in non-diluted human urine, with re-
coveries between 70 and 100% for most analytes except for SMI (52% 
recovery). For the first time, the extraction of metabolites (3-hydrox-
ydiclofenac and 5-hydroxydiclofenac) has been satisfactorily demon-
strated in microfluidic systems with recoveries between 71 and 100% in 
human urine. Despite the high selectivity and specificity that has been 
demonstrated so far by LPME, this work opens new application strate-
gies with LPME for the selective extraction of compounds of a very 
different nature. 
Fig. 4. Extraction efficiency versus donor flow rate. SLM: NPOE, donor phase pH: 3.5, acceptor phase pH: 11.5, acceptor flow rate: 1 μL min− 1.  
Table 2 
Method detection limit (MLOD), method quantitation limit (MLOQ) and extraction efficiencies at optimal conditions.  
Analyte AOX SDI SMI TMF EtP FLU PrP 3-OH 5-OH DIC 
% EE a 98 (3) 54 (3) 58 (2) 35 (1) 102 (2) 110 (1) 102 (3) 97 (3) 85 (2) 99 (1) 
MLOD (μg mL− 1) 0.8 0.04 0.1 0.25 0.1 0.25 0.1 0.25 0.8 0.04 
MLOQ (μg mL− 1) 2.7 0.1 0.3 0.83 0.3 0.83 0.3 0.83 2.6 0.14  
a % Extraction efficiency (%RSD, n = 4). 
Table 3 
Recoveries (average of three determinations ± standard deviation) from spiked 
urine samples.  
Analyte Spiked level (µg/mL) Recovery (%) (n = 4) 
AOX 3 68.1 ± 2.5 
5 70.2 ± 5.5 
SDI 0.2 69.4 ± 4.5 
2 71.7 ± 3.3 
SMI 0.5 52.4 ± 4.7 
2 55.8 ± 6.6 
TMF 2 91.9 ± 1.8 
5 93.1 ± 2.2 
EtP 0.5 98.7 ± 3.9 
2 99.0 ± 2.6 
FLU 2 95.1 ± 1.8 
5 97.4 ± 2.0 
PrP 0.5 100.2 ± 3.3 
2 98.4 ± 4.2 
3-OH 0.7 101.1 ± 1.7 
2 96.6 ± 2.4 
5-OH 2 71.4 ± 6.1 
5 73.9 ± 5.5 
DIC 0.2 99.7 ± 1.9 
1 99.3 ± 4.6  
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